Market Overview

UPDATE: Morgan Stanley Raises PT to $35 on Paychex on Organic Growth Outlook

Share:
Related PAYX
ADP Vs. Paychex: Bank Of America Changes Its Preference
5 Stocks To Watch For The Week Of October 30
Has Ackman's Influence Pushed Automatic Data Processing Beyond Its Fair Value? (Seeking Alpha)

Morgan Stanley reiterated its Neutral rating on Paychex (NASDAQ: PAYX) but raised its price target from $32 to $35.

Morgan Stanley commented, "We are positive on the payroll processing sector but see less upside for PAYX due to (1) weaker cycle to cycle earnings improvement, (2) less-attractive capital allocation, and (3) slow recovery for SMB clients coming out of the downturn. … Our estimates are unchanged from our previous publishing but we increase our multiple from 19.5X as our organic growth analysis still shows nearly 20pp improvement over the previous employment cycle"

Paychex closed at $33.37 on Thursday.

Latest Ratings for PAYX

DateFirmActionFromTo
Dec 2017Bank of AmericaMaintainsBuyBuy
Dec 2017CitigroupUpgradesSellNeutral
Oct 2017Wells FargoMaintainsMarket Perform

View More Analyst Ratings for PAYX
View the Latest Analyst Ratings

Posted-In: Morgan StanleyAnalyst Color Price Target Pre-Market Outlook Analyst Ratings

 

Related Articles (PAYX)

View Comments and Join the Discussion!